Orthopedic Surgery Doctors in Centralia, WA Accepting Medicare

5 Orthopedic Surgery doctors found. Showing 1 - 5

Dr. Chad Bender, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 Cooks Hill Rd, Centralia, WA 98531 Phone: 360-330-1897

Keith V Anderson, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1900 Cooks Hill Rd, Centralia, WA 98531 Phone: 360-736-2889    Fax: 360-736-3136

Scott C Slattery, MD Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 1900 Cooks Hill Rd, Centralia, WA 98531 Phone: 360-736-2899    Fax: 360-736-3136

Keith R Birchard, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 Cooks Hill Rd, Centralia, WA 98531 Phone: 360-736-2886    Fax: 360-736-3136

Christopher A Hawkins, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 Cooks Hill Rd, Centralia, WA 98531 Phone: 360-330-1874    Fax: 610-973-1778

News Archive

Partnership for Quality Home Healthcare applauds introduction of Better Care, Lower Cost Act of 2014

The Partnership for Quality Home Healthcare – a coalition of home health providers dedicated to improving the integrity, quality, and efficiency of home healthcare for our nation's seniors – today commended Senator Ron Wyden (D-OR), Senator Johnny Isakson (R-GA), Congressman Erik Paulsen (R-MN) and Congressman Peter Welch (D-VT) for introducing the Better Care, Lower Cost Act of 2014 (S.1932/H.R.3890) to improve the management of care for Medicare beneficiaries living with chronic conditions.

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum (WMF) 2021 (poster #: 5574).

OncoSec to present data from head and neck cancer studies at two upcoming conferences

OncoSec Medical Incorporated., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that the company has been selected to present data from its Phase III and IV head and neck cancer studies at two upcoming conferences.

Bioartificial kidney speeds recovery, reduces mortality

Another promising clinical trial for the bioartificial kidney is offering researchers even more hope that within the next few years the device will be available to save lives of patients with acute renal failure.

Read more Medical News

› Verified 5 days ago